Lisa Ooi, PhD, is Vice President (Healthcare & Wellness) at the Singapore Economic Development Board. She has previous experience at ASLAN Pharmaceuticals, Bayer Healthcare and the Agency for Science Technology and Research (A*STAR). Lisa has more than 15 years of experience in the biomedical industry in the areas of hematology, oncology biomarker development, clinical pharmacology, preclinical and clinical development, as well as large-scale private and public research partnerships and investment promotion.
Lisa is also a member of the Expert Committee on COVID-19 vaccination which makes recommendations to the Singapore government on the COVID-19 vaccination strategy. Lisa holds a BSc in Biochemistry from the University of Wisconsin-Madison, a MSc and PhD from Stanford University in Chemical Engineering and Chemical and Systems Biology.